Literature DB >> 35146695

It Is Premature to Use Postmortem Sperm for Reproductive Purposes: a Data-Driven Opinion.

Juan J Tarín1,2, Miguel A García-Pérez3,4, Antonio Cano3,5,6.   

Abstract

Postmortem sperm retrieval for reproductive purposes is an assisted reproduction procedure that offers women an opportunity to have a child using sperm retrieved from their deceased partners. The ethical issues of this procedure have been discussed in previous works. However, an assessment of the procedure using a scientific perspective is still lacking. Here, we aim to ascertain, using a biological standpoint, whether postmortem sperm should be rescued for reproductive purposes. Data suggest that it is premature to use postmortem sperm for reproductive purposes. This procedure should not be clinically applied until appropriate and comprehensive analyses have been completed. Such analyses should be focused not only on fertilization, embryo development, and pregnancy outcomes, but also on potential postmortem alterations of sperm DNA, RNAs, and proteins. In addition, genetic and epigenetic analyses of sperm, pre-implantation embryos, and newborns, as well as mental and physical health follow-up of the resulting offspring during a whole life cycle, using appropriate non-human mammalian models, are warranted.
© 2022. The Author(s).

Entities:  

Keywords:  Assisted reproduction technology; Coding and non-coding RNAs; Epigenetic changes; Interval from death to sperm retrieval; Offspring; Postmortem protein, DNA, and RNAs degradation

Year:  2022        PMID: 35146695     DOI: 10.1007/s43032-022-00874-6

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  34 in total

1.  Adjuncts in the IVF laboratory: where is the evidence for 'add-on' interventions?

Authors:  Joyce Harper; Emily Jackson; Karen Sermon; Robert John Aitken; Stephen Harbottle; Edgar Mocanu; Thorir Hardarson; Raj Mathur; Stephane Viville; Andy Vail; Kersti Lundin
Journal:  Hum Reprod       Date:  2017-03-01       Impact factor: 6.918

Review 2.  Embryo responses to stress induced by assisted reproductive technologies.

Authors:  Priscila Ramos-Ibeas; Sonia Heras; Isabel Gómez-Redondo; Benjamín Planells; Raúl Fernández-González; Eva Pericuesta; Ricardo Laguna-Barraza; Serafín Pérez-Cerezales; Alfonso Gutiérrez-Adán
Journal:  Mol Reprod Dev       Date:  2019-02-04       Impact factor: 2.609

3.  Evaluating risk, safety and efficacy of novel reproductive techniques and therapies through the EuroGTP II risk assessment tool.

Authors:  Esteve Trias; Martine Nijs; Ioana Adina Rugescu; Francesco Lombardo; Gueorgui Nikolov; Veerle Provoost; Annelies Tolpe; Nathalie Vermeulen; Zdravka Veleva; Rita Piteira; Ricardo Casaroli-Marano; Kelly Tilleman
Journal:  Hum Reprod       Date:  2020-08-01       Impact factor: 6.918

4.  Do we need an RCT for everything?

Authors:  J L H Hans Evers
Journal:  Hum Reprod       Date:  2017-03-01       Impact factor: 6.918

Review 5.  Assisted reproductive technology results: why are live-birth percentages so low?

Authors:  Juan J Tarín; Miguel A García-Pérez; Antonio Cano
Journal:  Mol Reprod Dev       Date:  2014-06-25       Impact factor: 2.609

6.  Children of the Dead: Posthumous Conception, Critical Interests and Consent.

Authors:  Neil Maddox
Journal:  J Law Med       Date:  2020-04

7.  A discussion supporting presumed consent for posthumous sperm procurement and conception.

Authors:  Kelton Tremellen; Julian Savulescu
Journal:  Reprod Biomed Online       Date:  2014-10-13       Impact factor: 3.828

8.  Fertility interventions 'add-ons' in clinical ART practice: Ethical, Moral and Commercial Considerations.

Authors:  Bindu N Chimote; Natchandra M Chimote
Journal:  J Assist Reprod Genet       Date:  2021-08-13       Impact factor: 3.357

9.  Postmortem parenthood and the need for a protocol with posthumous sperm procurement.

Authors:  Frances R Batzer; Joshua M Hurwitz; Arthur Caplan
Journal:  Fertil Steril       Date:  2003-06       Impact factor: 7.329

10.  A practical blueprint to systematically study life-long health consequences of novel medically assisted reproductive treatments.

Authors:  Callista L Mulder; Joana B Serrano; Lisa A E Catsburg; Tessa J Roseboom; Sjoerd Repping; Ans M M van Pelt
Journal:  Hum Reprod       Date:  2018-05-01       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.